Clinical Trial Update: Atenolol Exposure as Risk for Adverse Metabolic Responses to Beta Blockers [NA]

View source ↗

Summary

A completed clinical trial evaluated whether atenolol exposure increases the risk of adverse metabolic responses when using beta blockers in hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Atenolol (Atenolol)

Snippet

Sponsor: University of Florida | Conditions: Hypertension | NA | Status: COMPLETED